APA (7th ed.) Citation

Kimura, K., Hayashi, K., Sato, M., Nakaya, Y., Suzuki, A., Takaku, N., . . . Kobayashi, Y. (2025). Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). Diagnostics (2075-4418), 15(21), 2723. https://doi.org/10.3390/diagnostics15212723

Chicago Style (17th ed.) Citation

Kimura, Koichi, et al. "Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)." Diagnostics (2075-4418) 15, no. 21 (2025): 2723. https://doi.org/10.3390/diagnostics15212723.

MLA (9th ed.) Citation

Kimura, Koichi, et al. "Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)." Diagnostics (2075-4418), vol. 15, no. 21, 2025, p. 2723, https://doi.org/10.3390/diagnostics15212723.